New Immunotherapy Treatment Shows Promise for Prostate Cancer
Researchers in Canada are developing a new immunotherapy for prostate cancer using “masked” T-cell activators to bypass the body’s immune defenses and target tumors more effectively. According to reports from Radio-Canada and Acadie Nouvelle, this approach aims to activate T-lymphocytes—the immune system’s primary attackers—specifically within the tumor environment to reduce systemic side effects and improve … Read more